4-Bromo-2-propoxypyridine

Catalog No.: 
ACSFYT512
CAS No.: 
1142194-49-7
Molecular Formula: 
C8H10BrNO
Molecular Weight: 
216.08
4-Bromo-2-propoxypyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$122.00InquiryInquiry
1g95%$380.00InquiryInquiry
5g95%$1862.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-2-propoxypyridine
IUPAC Name4-bromo-2-propoxypyridine
MDL No.MFCD11869631
Molecular FormulaC8H10BrNO
Molecular Weight216.08
SMILESCCCOC1=NC=CC(Br)=C1
InChI KeyGURVVNJEKYHFPI-UHFFFAOYSA-N
Synonym4-broMo-2-propoxypyridine;4-Bromo-2-(n-propoxy)pyridine;Pyridine, 4-bromo-2-propoxy-
CAS No.1142194-49-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSFYT512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJXUM950 route compound structure diagram
    ACJXUM95073583-37-6In Stock
  4. Then
  5. ACSFYT512 route product structure diagram
    ACSFYT5121142194-49-7
Inquiry

2. ACSFYT512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJXUM950 route compound structure diagram
    ACJXUM95073583-37-6In Stock
  4. Then
  5. ACSFYT512 route product structure diagram
    ACSFYT5121142194-49-7
Inquiry

3. ACSFYT512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEWIQ271 route compound structure diagram
    ACEWIQ271128071-98-7In Stock
  4. Then
  5. ACSFYT512 route product structure diagram
    ACSFYT5121142194-49-7
Inquiry

Comments (0)